Contemporary radiation therapy in combined modality therapy for Hodgkin lymphoma

Amol K. Narang, Stephanie A. Terezakis

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The advent of effective combination chemotherapy markedly changed the management of Hodgkin lymphoma, establishing combined modality therapy as the standard of care for most patients with this disease. In response, significant interest has been shown in refining the delivery of radiation in the combined modality setting such that toxicity is minimized while still preserving disease control. An understanding of the way in which radiation treatment fields, prescription dose, and advanced technology have evolved to accomplish these goals is critical. Moreover, fluency in the clinical literature exploring contemporary questions, such as the omission of radiation and response-based treatment, is equally important. Knowledge of these topics will yield both an apprecia-tion of the value of radiation in the combined modality setting and the ability to better customize treatment regimens to individual patients.

Original languageEnglish (US)
Pages (from-to)597-604
Number of pages8
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© JNCCN - Journal of the National Comprehensive Cancer Network.

Fingerprint Dive into the research topics of 'Contemporary radiation therapy in combined modality therapy for Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this